A Ligand for Peroxisome Proliferator-Activated Receptor γ Inhibits Human Cholangiocarcinoma Cell Growth: Potential Molecular Targeting Strategy for Cholangioma

Author： Kobuke T.   Tazuma S.   Hyogo H.   Chayama K.  

Publisher： Springer Publishing Company

ISSN： 0163-2116

Source： Digestive Diseases and Sciences, Vol.51, Iss.9, 2006-09, pp. : 1650-1657

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome Proliferator-Activated Receptor γ as a Novel Therapeutic Target in Asthma

By Park Seoung Ju   Lee Yong Chul  

Journal of Asthma, Vol. 45, Iss. 1, 2008-01 ,pp. : 1-8

Informa Healthcare

Access to resources Recommend Favorite

Targeting Peroxisome Proliferator-Activated Receptor Gamma for Generation of Antidiabetic Drug

By  

Current Diabetes Reviews, Vol. 9, Iss. 4, 2013-07 ,pp. : 275-285

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator Activated Receptor-γ (PPAR-γ) Ligands and Angiogenesis

By Margeli A.   Kouraklis G.   Theocharis S.  

Angiogenesis, Vol. 6, Iss. 3, 2003-01 ,pp. : 165-169

Springer Publishing Company

Access to resources Recommend Favorite

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation in the Treatment of Hypertension and Metabolic Syndrome: The Role of Angiotensin II Receptor Blockers

By Borghi Claudio  

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 3, 2006-01 ,pp. : 81-84

Adis International

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor- in macrophage lipid homeostasis

By Lee C.-H.   Evans R.M.  

Trends in Endocrinology and Metabolism, Vol. 13, Iss. 8, 2002-10 ,pp. : 331-335

Elsevier

Access to resources Recommend Favorite